Ministry of Education
Amit Janu
VIDWAN ID: 171445

Dr Amit Janu

Male
Associate Professor | Clinical Research Centre
Advanced Centre for Treatment, Research and Education in Cancer
Maharashtra
Expertise: Radiology Nuclear Medicine and Medical Imaging
Scopus 57039008900
View older version My Dashboard
129 Publications
0 Projects
1500 Scopus Citations
1423 CrossRef
12 Years 11 Months Total Experience
Publications
129 Total
Articles
127
Chapters
1
Proceedings
1
Activity

No publication activity to display.

Scopus Scopus
1,500 Citations
15 h-index
CrossRef CrossRef
1,423 Citations
15 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Personal Details

No Information Available

No information is available at this time.

Associate Professor
Oct 2013 – Present
Advanced Centre for Treatment, Research and Education in Cancer | Clinical Research Centre
Medical and Health Sciences
Radiology Nuclear Medicine and Medical Imaging

Related Profiles

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Gefitinib versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-mutated lung cancer

Journal Article
Journal of Clinical Oncology. Year: 2020. Volume: 38 , Issue: 2 , Pages: 124-136 .
Authors: Vanita Noronha; Vijay Maruti Patil; Amit Joshi; Nandini Menon; Anuradha Chougule; Abhishek Mahajan; Amit Janu; Nilendu Purandare; Rajiv Kumar; Sucheta More; Supriya Goud; Nandkumar Kadam; Nilesh Daware; Atanu Bhattacharjee; Srushti Shah; Akanksha Yadav; Vaishakhi Trivedi; Vichitra Behel; Amit Dutt; Shripad Dinanath Banavali; Kumar Prabhash
DOI 10.1200/JCO.19.01154 Crossref Crossref: 366 Scopus Scopus: 403

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer.

Open Access
Journal Article
Oncotarget. Year: 2019. Volume: 10 , Issue: 59 , Pages: 6297-6307 .
Authors: Patil V; Joshi A; Noronha V; Agarwala V; Chougule A; Kanan S; Bhattacharjee A; Chandrasekharan A; Pande N; Simha V; Goud S; More S; Kumar R; Prabhash K
DOI 10.18632/oncotarget.27214 Crossref Crossref: 1 Scopus Scopus: 3

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.

Open Access
Journal Article
EClinicalMedicine. Year: 2019. Volume: 9 , Pages: 19-25 .
Authors: Patil V; Noronha V; Joshi A; Chougule A; Kannan S; Bhattacharjee A; Goud S; More S; Chandrasekharan A; Menon N; Srinivas S; Vallathol DH; Dsouza H; Prabhash K
DOI 10.1016/j.eclinm.2019.03.011 Crossref Crossref: 7 Scopus Scopus: 8

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

Open Access
Journal Article
Lung India. Year: 2018. Volume: 35 , Issue: 1 , Pages: 27 .
Authors: Kumar Prabhash; Amit Joshi; Vijay Patil; Vanita Noronha; Anuradha Chougule; Atanu Bhattacharjee; Rajiv Kumar; Supriya Goud; Sucheta More; Anant Ramaswamy; Ashay Karpe; Nikhil Pande; Arun Chandrasekharan; Alok Goel; Vikas Talreja; Abhishek Mahajan; Amit Janu; Nilendu Purandare
DOI 10.4103/lungindia.lungindia_201_17 Crossref Crossref: 2 Scopus Scopus: 5

Tyrosine kinase inhibitor versus physician choice chemotherapy in second-line epidermal growth factor receptor mutation non-small cell lung cancer: Post hoc analysis of randomized control trial

Open Access
Journal Article
Indian Journal of Medical and Paediatric Oncology. Year: 2018. Volume: 39 , Issue: 04 , Pages: 493-498 .
Authors: Noronha, V.; Pandey, A.; Patil, V.; Joshi, A.; Choughule, A.B.; Bhattacharjee, A.; Kumar, R.; Goud, S.; More, S.; Ramaswamy, A.; Karpe, A.; Pande, N.; Chandrasekharan, A.; Goel, A.; Talreja, V.; Mahajan, A.; Janu, A.; Purandare, N.; Prabhash, K.
DOI 10.4103/ijmpo.ijmpo_219_17

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

Open Access
Journal Article
ecancermedicalscience. Year: 2017. Volume: 11 .
Authors: Vanita Noronha; Vijay Patil; Amit Joshi; Anuradha Chougule; Atanu Bhattacharjee; Rajiv Kumar; Sucheta More; Supriya Goud; Ashay Karpe; Anant Ramaswamy; Nikhil Pande; Arun Chandrasekharan; Alok Goel; Vikas Talreja; Abhishek Mahajan; Amit Janu; Nilendu Purandare; Kumar Prabhash
DOI 10.3332/ecancer.2017.776 Crossref Crossref: 1 Scopus Scopus: 3

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Open Access
Journal Article
ESMO Open. Year: 2017. Volume: 2 , Issue: 1 , Pages: e000168 .
Authors: Vijay Maruti Patil; Vanita Noronha; Amit Joshi; Anuradha Bharat Choughule; Atanu Bhattacharjee; Rajiv Kumar; Supriya Goud; Sucheta More; Anant Ramaswamy; Ashay Karpe; Nikhil Pande; Arun Chandrasekharan; Alok Goel; Vikas Talreja; Abhishek Mahajan; Amit Janu; Nilendu Purandare; Kumar Prabhash
DOI 10.1136/esmoopen-2017-000168 Crossref Crossref: 57 Scopus Scopus: 59

Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer

Open Access
Journal Article
Cancer Research, Statistics, and Treatment. Year: 2019. Volume: 2 , Issue: 1 , Pages: 21-27 .
Authors: Kumar Prabhash; Vijay Patil; Vanita Noronha; Amit Joshi; Anuradha Chougule; Atanu Bhattacharjee; Alok Goel; Vikas Talreja; Nandini Menon; Anant Ramaswamy; Ashay Karpe; Nikhil Pande; Arun Chandrasekharan; Abhishek Mahajan; Amit Janu; Nilendu Purandare
DOI 10.4103/CRST.CRST_17_19 Scopus Scopus: 2
Showing 1 to 8 of 129 publications